BENITEC BIOPHARMA LIMITED (BLT)

Biotechnology, research and development.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
BLT	0.016	6.67%	0.015	0.016	0.015	0.017	0.015	7,438,217

BENITEC BIOPHARMA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	BLT
Securities	ASX Code, Security Description ------------------------------ BLT, Ordinary Fully Paid BLTO, Option Expiring 08-apr-2014 BLTOB, Option Expiring 31-dec-2013
Official Listing Date	17 February, 1997
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.benitec.com
Registered Office Address	Level 16, 356 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone	(02) 9555 6986
Head Office Fax	(03) 8678 1342
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Peter Francis (Non Exec. Chairman) Dr Peter French (CEO) Mr Mel Bridges (Non Exec. Director) Mr Kevin Buchi (Non Exec. Director) Dr John Chiplin (Non Exec. Director) Mr Iain Ross (Non Exec. Director)

Company Secretary	Mr Greg West
Principal Activities	Biotechnology, research and development.

BENITEC BIOPHARMA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
17/06/2013		Notice of General Meeting/Proxy Form	31	PDF
14/06/2013		s708 Cleansing Statement	1	PDF
14/06/2013		Appendix 3B	13	PDF
14/06/2013		US COURT DECISION POSITIVE FOR BENITEC	1	PDF
13/06/2013		R&D TAX CREDIT RECEIVED	1	PDF
12/06/2013		FAVOURABLE RAC REVIEW	1	PDF
06/06/2013		Reinstatment to Official Quotation	1	PDF
06/06/2013		CAPITAL RAISING AUD7 MILLION PLACEMENT	2	PDF
05/06/2013		Suspension from official quotation	2	PDF
03/06/2013		Trading Halt	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
18 Jun 2013	0.015	0%	0.015	0.015	502,933
17 Jun 2013	0.015	0%	0.015	0.015	400,000
14 Jun 2013	0.015	7.14%	0.015	0.014	1,345,333
13 Jun 2013	0.014	7.69%	0.015	0.014	1,033,501
12 Jun 2013	0.013	8.33%	0.015	0.012	9,209,973

* Volume of shares shown represents only those shares traded on ASX.

BENITEC BIOPHARMA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BLT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BLT

Warrants & Structured Products

No warrants & Structured Products are available over the security BLT

ASX CFDs

No Contracts For Differences are available over the security BLT

MyASX: Login | Sign up